J Pathol Transl Med.  2017 Nov;51(6):517-520. 10.4132/jptm.2017.09.27.

Current Practices of Thyroid Fine-Needle Aspiration in Asia: A Missing Voice

• Bychkov A
• Kakudo K
• Hong S

• KMID: 2396532
• DOI: http://doi.org/10.4132/jptm.2017.09.27

Abstract

No abstract available.

MeSH Terms

Asia*
Biopsy, Fine-Needle*
Thyroid Gland*
Voice*

Figure

• 

  Fig. 1. Members of the Working Group of Asian Thyroid FNA Cytology and hosts during the inaugural meeting of the 12th Asia and Oceania Thyroid Association (AOTA) congress in Busan, Korea (March 16, 2017). FNA, fine-needle aspiration. Left-to-right: Z. Liu (China), K. Kakudo (Japan), C.R. Lai (Taiwan), S. Satoh (Japan), S. Keelawat (Thailand), S. Canberk (Turkey), A. Bychkov (Thailand), S.W. Hong (Korea), D.E. Song (Korea), C.K. Jung (Korea), H.J. Kwon (Korea), M. Hirokawa (Japan), H.K. Chang (Korea).

Reference

1. Dong J. The relationship between traditional Chinese medicine and modern medicine. Evid Based Complement Alternat Med. 2013; 2013:153148.

2. Shrivastava SR, Shrivastava PS, Ramasamy J. Mainstreaming of Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy with the health care delivery system in India. J Tradit Complement Med. 2015; 5:116–8.

3. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer;2013. [cited 2016 Oct 18]. Available from: http://globocan.iarc.fr.

4. Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes. 2017; 24:332–6.

5. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer “epidemic”: screening and overdiagnosis. N Engl J Med. 2014; 371:1765–7.

6. Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016; 375:614–7.

7. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003; 13:381–7.

8. Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016; 4:933–42.

9. Japan Thyroid Association. Guidelines for clinical practice for the management of thyroid nodules in Japan 2013. Tokyo: Nankodo Co., Ltd;2013.

10. Yi KH. The revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers: differences from the 2015 American Thyroid Association guidelines. Endocrinol Metab (Seoul). 2016; 31:373–8.

11. Chindavijak S, Panchan V, Chaiwerawattana A, Imsamran W. Guidelines for the diagnosis and treatment of thyroid cancer. Bangkok: Kosit Press Co., Ltd;2015.

12. Sison CM, Obaldo J, Matsuo J, Uy GL, Jaring C. University of the Philippines - Philippine General Hospital revised clinical practice guidelines for the management of well-differentiated thyroid carcinoma of follicular cell origin. J Asean Fed Endocr Soc. 2012; 27:49–61.

13. Unnikrishnan AG, Kalra S, Baruah M, et al. Endocrine Society of India management guidelines for patients with thyroid nodules: a position statement. Indian J Endocrinol Metab. 2011; 15:2–8.

14. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26:1–133.

15. Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009; 132:658–65.

16. Pusztaszeri M, Rossi ED, Auger M, et al. The Bethesda System for Reporting Thyroid Cytopathology: proposed modifications and updates for the second edition from an international panel. Acta Cytol. 2016; 60:399–405.

17. Cross P, Chandra A, Giles T, et al. Guidance on the reporting of thyroid cytology specimens. 2nd ed. London: Royal College of Pathologists;2016.

18. Kakudo K, Kameyama K, Miyauchi A, Nakamura H. Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association. Endocr J. 2014; 61:539–52.

19. Nardi F, Basolo F, Crescenzi A, et al. Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest. 2014; 37:593–9.

20. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012; 56:333–9.

21. Krauss EA, Mahon M, Fede JM, Zhang L. Application of the Bethesda classification for thyroid fine-needle aspiration: institutional experience and meta-analysis. Arch Pathol Lab Med. 2016; 140:1121–31.

22. Sheffield BS, Masoudi H, Walker B, Wiseman SM. Preoperative diagnosis of thyroid nodules using the Bethesda System for Reporting Thyroid Cytopathology: a comprehensive review and meta-analysis. Expert Rev Endocrinol Metab. 2014; 9:97–110.

23. Straccia P, Rossi ED, Bizzarro T, et al. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol. 2015; 123:713–22.

24. Kim M, Park HJ, Min HS, et al. The use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: a nationwide multicenter survey by the Korean Society of Endocrine Pathologists. J Pathol Transl Med. 2017; 51:410–7.

25. Choudhary PK, Nepal N, Mainali N, Meenakshi B. Implementation of Bethesda system in thyroid aspirate: a cyto-histopathological correlation study. J Pathol Nepal. 2016; 6:902–5.

26. Hassan MQ, Hasanat MA, Fariduddin M, et al. Fine needle aspiration cytological diagnosis of thyroid nodule with its clinical correlation. Bangabandhu Sheikh Mujib Med Univ J. 2013; 6:108–15.

27. Kakudo K. How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules. Gland Surg. 2017; Aug. 2. [Epub]. https://doi.org/10.21037/gs.2017.08.02.

28. Kakudo K, Higuchi M, Hirokawa M, Satoh S, Jung CK, Bychkov A. Thyroid FNA cytology in Asian practice–Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinoma. Cytopathology. 2017; [Epub]. https://doi.org/10.1111/cyt.12491.

29. Bychkov A, Hirokawa M, Jung CK, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Thyroid. 2017; 27:983–4.

30. Liu Z, Zhou G, Nakamura M, et al. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal. Cancer Sci. 2011; 102:288–94.

31. Kakudo K, Liu Z, Hirokawa M. Thyroid FNA cytology: differential diagnoses and pitfalls. Nara: Kakudo Medical Education;2016.

32. Canberk S, Baloch ZW, Ince U, Schmitt F. Diagnosis of non-invasive follicular tumor with papillary-like nuclear features (NIFTP): a practice changer for thyroid fine-needle aspiration interpretation. J Basic Clin Med. 2017; 6:38–43.

33. Jung CK, Kim C. Effect of lowering the diagnostic threshold for encapsulated follicular variant of papillary thyroid carcinoma on the prevalence of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institution experience in Korea. J Basic Clin Med. 2017; 6:26–8.

34. Kakudo K. Unsettled issues in non-invasive encapsulated/wellcircumscribed follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and precursor thyroid tumors. J Basic Clin Med. 2017; 6:3–7.

35. Kakudo K, Liu Z, Satoh S, Higuchi M, Hirokawa M. Non-invasive follicular thyroid neoploasm with papillary-like nuclear features (NIFTP): diagnosis and differential diagnoses. J Basic Clin Med. 2017; 6:14–21.

36. Bychkov A, Keelawat S, Agarwal S, et al. Impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda System for Reporting Thyroid Cytopathology: a multiinstitutional study in five Asian countries. Pathology. Forthcoming.